Back to News Releases
Date: November 25, 2009
Contact:
Michele Fisher
Media Relations Specialist
The Cancer Institute of New Jersey
Ph:732-235-9872
fisherm2@umdnj.edu
Leadership Award Given to Chief Scientific Officer and Associate Director of The Cancer Institute of New Jersey
Dr. Joseph R. Bertino Recognized for Contributions to Lymphoma Research Foundation
New Brunswick, N.J., November 25, 2009 – In recognition of efforts made to assist the Lymphoma Research Foundation (LRF) in its mission to eradicate lymphoma and reach out to those touched by the disease, Joseph R. Bertino, MD, associate director and chief scientific officer at The Cancer Institute of New Jersey (CINJ) and university professor of medicine and pharmacology at UMDNJ-Robert Wood Johnson Medical School, was recently honored with the Freundlich Leadership Award. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The Freundlich Leadership Award is given to those who make an extraordinary effort to assist LRF through the Scientific Advisory Board. Dr. Bertino, founder of LRF’s Scientific Advisory Board, is a world-renowned medical oncologist and researcher internationally recognized for his role in finding curative treatments for leukemia and lymphoma.
Bertino, a Franklin Township (Somerset County) resident, is the author or co-author of more than 400 scientific publications, and is currently leading his laboratory in the study of developing new therapies for lymphoma and the use of drug resistant genes to protect bone marrow from chemotherapy toxicity.
About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center, and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. The Cancer Institute of New Jersey is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. To support CINJ, please call the Cancer Institute of New Jersey Foundation at 1-888-333-CINJ.
The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, and Jersey Shore University Medical Center. Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, Cooper University Hospital*, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ at Hamilton), Saint Peter’s University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate
###
